Coriander

Coriander (Coriandrum sativum L.): A Comprehensive Reference

1. Identity and Botanical Classification

Scientific Name and Taxonomy

Coriandrum sativum L. is an annual herb belonging to the family Apiaceae (formerly Umbelliferae). The name of this species is derived from the Greek word Korion, meaning "bug," an allusion to the distinctive odor of the immature plant. In Sanskrit literature, coriander is referred to as kusthumbari or dhanayaka; in Hindi it is called Dhania, while Dhane is used in Bengali. It is a native plant of the eastern Mediterranean from where it may have spread to India, China, and the rest of the world.

Common Names

In English, the plant is known as both "Coriander" and "Cilantro," and as "Coriandre" in French. It belongs to the Apiaceae botanical family. The dried, mature fruits are universally referred to as "coriander seeds," while the fresh leaves and stems are called cilantro in North American culinary tradition and in much of Latin America.

Botanical Description and Plant Parts Used

The plant has both compound and simple leaves that are alternate on an erect stem. The flowers are bisexual, with blue/purple, pink/red, and white corollas. The fruits are dry schizocarps, and the flowers occur in flat, round umbels. The plant provides two types of herbal raw materials: fruits (seeds) and leaves, the main biologically active substance of which is essential oil (EO).

Two botanical varieties exist: vulgare Alef. and microcarpum DC. These differ in fruit size and oil yield: vulgare has fruits of 3–5 mm diameter and yields 0.1%–0.35% essential oil, while microcarpum fruits are 1.5–3 mm and yield 0.8%–1.8% essential oil.

Geographic Origin and Cultivation

Coriandrum sativum is an aromatic glabrous annual herb of the Apiaceae/Umbelliferae family, widely utilized for its nutritional and medicinal properties. It originated in the European-Mediterranean phytogeographic region and was then distributed all over the world. The leaves are among the most widely used flavoring herbs in the world. The dried seed is also used as a spice in many countries and is a major ingredient of Indian curry powder.

Common Forms and Preparations

• Dried whole seeds: Used as a spice in whole or ground form.
• Fresh leaves (cilantro): Fresh leaves and shoots of Coriandrum sativum are usually used as food seasonings.
• Essential oil (EO): Steam-distilled or hydrodistilled from seeds; the primary vehicle for medicinal applications.
• Fixed (fatty) oil (coriander seed oil, CSO): Cold-pressed from seeds, distinct from the volatile EO.
• Aqueous infusion (herbal tea): Coriander fruit is regulated as a herbal medicinal product (HMP) for oral use, prepared as a herbal tea, fluidextract, or as the essential oil, for treating loss of appetite, digestive disturbances with mild spasms of the gastrointestinal tract, distension, and flatulence.
• Powder and capsules: Used in clinical research, e.g., seed powder in gelatin capsules.
• Tinctures and fluid extracts: Standardized or hydroalcoholic preparations used historically in pharmacopoeias.

2. Traditional and Historical Use

Ancient Egypt and the Mediterranean

Coriandrum sativum is one of the oldest aromatic herbs, having been used as a food additive and for medicinal purposes for over 3,000 years. Archaeological evidence indicates that coriander seeds were found in ancient Egyptian tombs, suggesting their use in both culinary and ritual contexts. The ancient Greeks and Romans also prized coriander, using it in their cuisine and as a medicinal herb. Early physicians, including Hippocrates, used coriander for its medicinal properties, including as an aromatic stimulant.

Traditional Use Across Cultures

Coriander seed has been used as a medicine for thousands of years including in ancient Greece, Rome, China, and India, and the same digestive indications are recorded in each tradition. Beyond culinary use, coriander has appeared in folk medicine in many countries, including China, since ancient times.

In Sangam Tamil literature (~200 BCE–300 CE), coriander is lauded for alleviating indigestion in coastal communities. Egyptian physician accounts describe its diuretic action, and Greek physicians wrote about it around 400 BCE. In Tibetan medicine, a coriander seed decoction is traditionally given for mild respiratory congestion.

Ayurvedic Medicine (India)

Coriander seed is also known for its medicinal importance; in particular, the seeds are used for the preparation of Ayurveda medicines as well as used traditionally in different tribal communities for the preparation of various remedies. In Ayurveda, coriander is described as tridoshhar (equilibrium of vata, cough, and pitta), trishnanigrah (thirst control), rochan (laxative), deepan (appetizer), pachan (digestive), krimidhan (parasite killer), coughdhan (cough reducer), mutrajanan and mutravarjaniva (diuretic), jawarhan (antipyretic), and masteekbalya (brain tonic).

In classical Ayurveda, coriander, known as Dhaniyaka, is described in terms of herbal energetics: its taste (Rasa) is Madhura (sweet), Tikta (bitter), and Kashaya (astringent); its qualities (Guna) are Laghu (light) and Snigdha (slightly unctuous); and it is traditionally considered balancing for the Pitta and Kapha doshas. Historically and traditionally, coriander has been used to ease gastrointestinal discomfort. It famously makes up one-third of the Ayurvedic formula CCF Tea — three seeds used specifically to support appetite and the digestive and detoxification processes.

Regional customs vary: Maharashtrian folk remedies apply a paste of fresh leaves on the forehead to relieve headaches, while South Indian herbalists boil seeds with cumin for postpartum recovery.

Official Western Herbal Recognition

Coriander seed is listed in the German Commission E Monographs for alleviating digestive complaints and stimulating appetite. The German Pharmacopoeia also recognizes coriander seed as a source of essential oils that can effectively treat mild stomach cramps, flatulence, and colicky symptoms in the intestinal tract. The essential oil is considered spasmolytic, stomachic (stimulates digestive juices and aids digestion), carminative (reduces gas and bloating), and also has antibacterial and antifungal activity.

The seed is also recommended as a taste enhancer and can counteract the mild cramps accompanying the use of laxatives. In the historical British Pharmacopoeia, coriander was characterized as a stimulant, aromatic, and carminative. The powdered fruit, fluid extract, and oil were chiefly used medicinally as flavoring to disguise the taste of active purgatives and correct their griping tendencies, and it was an ingredient in compound preparations of the Pharmacopoeia including tincture and syrup of rhubarb.

3. Key Constituents and Active Compounds

Volatile (Essential) Oil

Coriander seeds contain approximately 2–2.6% essential oil, consisting of up to 55–74% linalool, with the remainder including other monoterpenes such as alpha- and beta-pinene, limonene, gamma-terpinene, p-cymene, anethole, geraniol, and camphor. The yield of essential oil varies from 0.03–2.6%, depending on the species, growing region, and climatic conditions. The major volatile compounds in coriander seed are: linalool (55.59%), γ-terpinene (7.47%), α-pinene (7.14%), camphor (5.59%), decanal (4.69%), geranyl acetate (4.24%), limonene (3.10%), geraniol (2.23%), camphene (1.78%), and D-limonene (1.36%).

The yield of the essential oil and its chemical composition change during ontogenesis, which affects the aroma of the plant; thus, the coriander fruit aroma is completely different from the aroma of the herb. Immature fruits and leaves have an unpleasant odor called a "stink bug smell," which is due to trans-tridecen contained in the oil. Oxygenated monoterpenes, especially linalool, are the major compounds in seed oils, followed by α-pinene, γ-terpinene, and geranyl acetate.

Fixed (Fatty) Oil

The seeds also contain 11–21% fixed oil including 4–17% oleic acid, 4–11% petroselinic acid, and 1.3–1.8% linolenic fatty acids, as well as coumarins, 5- and 8-methoxypsoralen, imperatorin, mucilage, flavonoids, tannins, approximately 20% sugars, 11–17% protein, and starch. Petroselinic acid is the major fatty acid in cold-pressed coriander seed oil (CSO). Among the seeds' main constituents are fatty acids (mostly petroselinic and linoleic) and sterols (mostly stigmasterol and β-sitosterol).

Polyphenols and Flavonoids

Coriander is rich in bioactive compounds such as flavonoids, polyphenols, and essential oils, which contribute to its antidiabetic and antihyperlipidemic activities. The total flavonoid content reported in leaves is 16.14 ± 1.17 mg of quercetin equivalents (QE)/g of dry extract, compared with 2.83 ± 0.20 mg QE/g dry weight for the stems. The hydroalcoholic extract of coriander stems and leaves contain flavonoids (3.70 ± 1.1 mg/100 g), flavonols (1.67 ± 0.5 mg/100 g), and tannins (2.80 ± 0.5 mg/100 g).

Key Compound: Linalool

The major compound, linalool, abundantly found in seeds, is noted for its abilities to modulate many key pathogenesis pathways of diseases. The potent antioxidant property of C. sativum provides a key mechanism behind its protective effects against neurodegenerative diseases, cancer, and metabolic syndrome. In coriander oil, linalool, its major component, is primarily found in the form of its S (+) enantiomer, known to induce increased permeability only in negatively charged membranes.

4. Mechanisms of Action

Antidiabetic and Metabolic Mechanisms

The mechanisms underlying coriander's antidiabetic and antihyperlipidemic effects include stimulation of insulin secretion, inhibition of α-glucosidase activity, modulation of lipid metabolism, and antioxidant activity. In animal studies, there was a significant increase in beta-hydroxy, beta-methyl glutaryl CoA reductase and plasma lecithin-cholesterol acyl transferase (LCAT) activity in experimental groups. The level of LDL + VLDL cholesterol decreased while that of HDL cholesterol increased compared to control groups.

Anxiolytic and Neurological Mechanisms

Coriander seed oil contains linalool (60–70%) as the major essential oil component. Linalool has marked effects at the CNS, including hypnotic and anticonvulsant properties, and anxiolytic and sedative effects are also shown by linalool in human subjects. The mechanism of action by which C. sativum shows anxiolytic activity may be similar to that of diazepam, which acts via the gamma-aminobutyric acid (GABA_A) receptor complex, as flavonoids and diazepam share this pathway.

Studies have revealed that some coriander compounds exhibit chemical interaction with γ-aminobutyric acid, 5-hydroxytryptamine, and N-methyl-D-aspartate receptors, which are key components in the pathophysiology associated with psychiatric and neurological diseases.

Anti-inflammatory Mechanisms

Coriander essential oil has demonstrated anti-inflammatory activities via increasing cytokines like IL-10 and IL-4, while limiting nitric oxide (NO), IFN-γ, and TNF-α release into cell supernatant. It significantly induced an anti-inflammatory effect via an increase in the release of anti-inflammatory cytokines but reduced the LPS-induced NO and TNF-α production at 0.16–0.3 mg/mL.

Antimicrobial Mechanisms

Linalool's ability to inhibit the growth of fungi and bacteria has been well documented. An antimicrobial study on resistant Klebsiella pneumoniae demonstrated the efficacy of linalool through membrane disruption. Additionally, γ-terpinene exhibits potent inhibitory activity against S. typhimurium and E. coli, and earlier research demonstrated potent antibacterial activity of γ-terpinene found in high concentrations in C. sativum.

5. Scientific Evidence by Area of Use

5.1 Digestive System

Coriander seeds have been used in treating numerous digestive complaints such as indigestion, nausea, and dysentery, while coriander leaves are also used to stimulate appetite and aid digestion. The Commission E monograph recognition (see Section 2) constitutes the strongest regulatory acknowledgment of coriander's digestive use. However, this regulatory listing reflects traditional use and safety data rather than large, randomized controlled clinical trials. The body of digestive evidence for coriander consists predominantly of traditional records across multiple cultures, pharmacopoeial listings, and pharmacological plausibility based on the spasmolytic and carminative properties of its EO.

Evidence strength: Moderate for traditional validity; supported by regulatory monographs (Commission E, German Pharmacopoeia); direct large-scale RCT evidence in humans is lacking for this indication.

5.2 Metabolic Health: Blood Glucose and Lipid Profile

Human Clinical Evidence

A key human RCT was published in 2025: A randomized, double-blinded, placebo-controlled trial aimed to study the effect of coriander seed supplementation on serum glycemic indices, lipid profile, and oxidative stress parameters in patients with T2DM. Eligible 40 T2DM patients aged 30–60 years were recruited from Sina Hospital (Tabriz, Iran) and randomly assigned into two groups to receive either coriander seed powder (1,000 mg/day, n=20) or placebo (1,000 mg/day, n=20) for 6 weeks. In this 6-week randomized controlled trial in 40 participants with type 2 diabetes, coriander seed powder improved markers of glycemic control and blood lipids, but there are reasons to be skeptical of these findings owing to the small sample size and short duration.

All inter-group variations were statistically significant (P<0.001) for glycemic, lipid, and oxidative stress parameters after adjustment for baseline values and potential confounders (age, sex). There is a limited number of studies regarding the effects of coriander seed on diabetes mellitus in human studies; particularly, no data existed prior to this trial to show its ameliorating effects on oxidative stress in T2DM patients.

Preclinical Evidence

Coriandrum sativum seeds at a dose of 100 mg/kg body weight and 200 mg/kg body weight for a period of 14 days showed a significant decrease in blood glucose levels in streptozotocin-induced diabetic Wistar rats. In Moroccan traditional medicine, aqueous extract of coriander seeds has been used for the treatment of diabetes, and a preclinical study investigated potential hypoglycemic and hypolipidemic activity after a single oral dose and after daily dosing for 30 days in normal and obese-hyperglycemic-hyperlipidemic (OHH) Meriones shawi rats. In alloxan-induced diabetic rats, coriander extracts lowered serum total cholesterol, triglycerides, and LDL cholesterol, while HDL cholesterol was higher than in diabetic control rats.

Evidence strength: Promising but preliminary for human use. The sole existing RCT is small (n=40) and of short duration. The animal and preclinical evidence is more extensive. Large, multicenter, long-duration trials are lacking.

5.3 Cardiovascular Health

A systematic review found that most studies covering cardiovascular benefits were in vivo, while only a few were in vitro and clinical studies. In conclusion, C. sativum can be deemed a functional food due to its wide range of cardiovascular benefits such as antihypertensive, anti-atherogenic, antiarrhythmic, hypolipidemic, as well as cardioprotective effects. The antihypertensive effect is documented primarily in animal models; human interventional data specific to blood pressure as an endpoint are not yet established in well-powered RCTs.

Evidence strength: Largely preclinical (animal/in vitro). Systematic review-level evidence acknowledges cardiovascular potential but notes the scarcity of human clinical trials.

5.4 Antimicrobial Activity

The essential oil of coriander shows high antibacterial activity against some important bacteria, including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Salmonella typhimurium, Salmonella choleraesuis, Bacillus subtilis, Pseudomonas aeruginosa, and Acinetobacter baumannii.

Investigations of the antimicrobial activities of coriander EO and its major compound, linalool, against Campylobacter jejuni and C. coli strains using disc diffusion test, vapor-phase method, and microdilution method found MICs of coriander EO and linalool ranging between 0.5 and 1 μL/mL. Coriander EO also showed inhibitory effects on the biofilm formation of Campylobacter spp.

In a study where the antibacterial activity of coriander essential oil, linalool, and their combinations with antibiotics were assessed by broth microdilution and checkerboard assays, 34 compounds were identified in coriander essential oil, with linalool (70.11%) being predominant. Coriander essential oil and linalool showed synergistic interactions with antibiotics (oxacillin, amoxicillin, gentamicin, ciprofloxacin, tetracycline) against both Gram-positive and Gram-negative bacteria.

The in vitro antimicrobial activity of coriander EO was assessed against five strains, including two gram-positive bacteria, two gram-negative bacteria, and one fungal strain (Candida albicans), with significant antibacterial and antifungal activities found against all strains using the disc-diffusion assay.

Evidence strength: Well-established in vitro and in laboratory settings. No clinical (human) trials have evaluated coriander EO as a primary antimicrobial therapeutic agent. Findings are primarily relevant to food preservation and basic pharmacology research.

5.5 Anxiolytic, Sedative, and Neurological Effects

Recent research has shown that Coriandrum sativum offers a rich source of metabolites, mainly terpenes and flavonoids, as useful agents against central nervous system disorders, with remarkable in vitro and in vivo activities on models related to these pathologies.

Using different animal models (elevated plus maze, open field test, light and dark test, and social interaction test) of anxiety in mice, diazepam (0.5 mg/kg) was used as the standard, and doses of hydroalcoholic extract of C. sativum fruit at 100 and 200 mg/kg produced anti-anxiety effects almost similar to diazepam, while 50 mg/kg did not produce anti-anxiety activity on any paradigm.

Several studies have indicated the positive effects of C. sativum on memory, anxiety, and depression. In one specific study, the aqueous extract derived from the seeds demonstrated significant reductions in monoamine oxidase-B (MAO-B) activity over time, suggesting its primary role in exerting antidepressant-like effects.

Results showed that extracts and EO of coriander exhibit sedative and hypnotic activities in pentobarbital-induced hypnotic models. In another study, the sleep-prolonging effects of fractions of aerial parts of the plant — including water (WF), ethyl acetate (EAF), and n-butanol (NBF) fractions — were confirmed in mice. The hydro-alcoholic extract, EAF, and NBF significantly prolonged sleep duration, but only the NBF decreased sleep latency significantly.

For human evidence, a registered randomized, triple-blind, placebo-controlled trial examined whether coriander seeds (500 mg capsules administered twice daily) could improve memory, alleviate anxiety and depression, and enhance sleep quality in university students (n=86 actual enrollment). Its clinical effectiveness was mentioned in a randomized, triple-blind, placebo-controlled study in which patients with migraine received syrup from the fruit of coriander and sodium valproate. The authors concluded that the intake of coriander caused a reduction in the duration, severity, and frequency of migraine.

The current clinical evaluations of standardized extracts of C. sativum are scarce; however, one or more of its compounds represents an area of opportunity to test the efficacy of the plant as an anxiolytic, antidepressant, antiepileptic, or sleep enhancer.

Evidence strength: Preclinical evidence (animal models) is consistent across multiple studies for anxiolytic, sedative, anticonvulsant, and memory-enhancing effects. Human clinical evidence is very limited — a single migraine trial and a small university-student RCT constitute the available data. This area requires well-powered human trials before clinical conclusions can be drawn.

5.6 Antioxidant Activity

The major volatile compound of coriander essential oil is β-linalool (66.07%), and the essential oil showed a radical scavenging activity of 51.05% inhibition in standard DPPH assay conditions. Based on in vitro antioxidant assay results, coriander EO has been found to have a superior antioxidant profile. Antioxidant activity has been confirmed across leaf and seed preparations using DPPH and ABTS assays in multiple independent laboratory studies, but this has not been tested as a standalone clinical intervention in human trials.

5.7 Skin Health

A randomized, placebo-controlled pilot trial of virgin coriander seed oil (200 mg/day) in women with reactive skin reported improvements in induced redness/itching and self-perceived sensitivity over 4–8 weeks. This pertains to a specific oil supplement under study conditions.

Evidence strength: Very preliminary. One small pilot RCT. Insufficient evidence for clinical recommendations.

6. Body Systems and Health Areas Associated with Coriander

• Gastrointestinal system: Carminative, antispasmodic, spasmolytic, stomachic, appetite-stimulating, antiemetic. Supported by traditional use across multiple cultures, Commission E listing, and German Pharmacopoeia.
• Metabolic/endocrine system: Antidiabetic (insulin secretion stimulation, α-glucosidase inhibition), antihyperlipidemic (LDL lowering, HDL raising), antiobesity. Supported mainly by preclinical evidence and one small human RCT.
• Cardiovascular system: Antihypertensive, anti-atherogenic, cardioprotective, antiarrhythmic. Primarily preclinical evidence; no powered human clinical trials.
• Central nervous system: Anxiolytic, sedative/hypnotic, anticonvulsant, antidepressant, neuroprotective, memory-enhancing. Primarily animal model evidence; very limited human data.
• Antimicrobial/immune system: Antibacterial, antifungal, antibiofilm activity against clinically relevant pathogens. Laboratory/in vitro evidence; synergism with conventional antibiotics demonstrated in vitro.
• Antioxidant: Demonstrated in vitro across multiple assay systems; not validated in human trials as a standalone intervention.
• Skin: Anti-inflammatory and soothing properties for reactive skin; one small pilot RCT with coriander seed oil.
• Diuretic: Pharmacological studies have demonstrated diuretic action, consistent with traditional descriptions across cultures.

7. Dosage Forms and Doses Reported in Studies

The following dosages are reported specifically from the cited sources and should not be interpreted as prescriptive recommendations.

• Seed powder (human RCT, type 2 diabetes): 1,000 mg/day (as capsules) for 6 weeks in a randomized, double-blind, placebo-controlled trial of T2DM patients aged 30–60 years.
• Seed powder in capsules (neurological RCT): 500 mg capsules administered twice daily (1,000 mg/day) in a trial investigating memory, anxiety, depression, and sleep in university students (n=86).
• Dried seed / infusion (Commission E / German Pharmacopoeia): The daily dose of coriander seed is 3 g of the dried seed or crushed seeds taken directly or as an infusion. To prepare an infusion: pour approximately 150 mL of boiling water over 1–2 teaspoonfuls of crushed and powdered coriander seed, cover, and after about 10–15 minutes strain.
• Coriander seed oil (novel food/supplement, EFSA): The novel food ingredient (CSO) is intended to be marketed as a food supplement for healthy adults at a maximum level of 600 mg per day (i.e., 8.6 mg/kg body weight per day for a 70 kg person).
• Hydroalcoholic extract (animal anxiolytic model): Doses of 50, 100, and 200 mg/kg were tested in mice, with 100 and 200 mg/kg producing effects comparable to diazepam 0.5 mg/kg.
• Essential oil (animal insulin-resistance model): Coriander essential oil at 1 mL/kg body weight significantly reversed the development of dexamethasone-induced insulin resistance in rats.
• Seed extract (animal diabetes model): Coriandrum sativum seeds at 100 mg/kg and 200 mg/kg body weight for 14 days showed a significant decrease in blood glucose levels in streptozotocin-induced diabetic Wistar rats.

8. Safety Considerations and Interactions

General Regulatory Status

The long history of use as a traditional medicine and flavoring agent, with no record of toxic effects, suggests that coriander essential oil and particularly its main constituent, linalool, can be considered as generally safe. In the food industry, coriander is approved for food use by the US Food and Drug Administration.

Allergic Reactions and Cross-Reactivity

Persons with known sensitivity to Apiaceae (Umbelliferae) plants — including caraway, celery, coriander, dill, and fennel — may experience cross-reactions. A common allergen called Bet v 1, also found in fennel, may account for observed cross-sensitivity, which can manifest as rhinitis, angioedema, asthma, wheezing, urticaria, eczema, abdominal pain, vomiting, and diarrhea. According to EMA assessment of related Apiaceae preparations, medicines should not be used in people who are hypersensitive (allergic) to related plants of the same Apiaceae family, including fennel, anise, celery, coriander, and dill.

Potential for Skin Sensitization

The only side effect that has been recorded for coriander EO is a weak potential for sensitization. Topical application of the essential oil in concentrated form may cause contact dermatitis in sensitized individuals, consistent with the broader Apiaceae family profile.

High-Dose Liver Effects (Preclinical)

There are no safety concerns regarding genotoxicity for coriander seed oil. However, in rats fed high amounts of CSO, increased liver weight, marked to severe fat infiltration in the liver, and lower tissue arachidonic acid concentrations were observed. These findings are preclinical and pertained to doses substantially higher than those proposed for human supplementation.

Drug Interactions: Additive Hypoglycemic and Antihypertensive Effects

Concentrated extracts may interact with glucose or blood-pressure medications. Given the demonstrated antidiabetic and antihypertensive mechanisms of coriander in preclinical models, co-administration of high-dose preparations with antidiabetic drugs (e.g., insulin, sulfonylureas) or antihypertensive agents could theoretically produce additive lowering of blood glucose or blood pressure; however, specific pharmacokinetic drug-interaction studies in humans are currently lacking.

Gaps and Limitations in the Safety Literature

Very few studies evaluating the toxic effects of coriander essential oil and its major component, linalool, have been published in the scientific literature, meaning the data available on long-term safety are limited. Long-term safety trials in diverse populations, standardized extract comparisons, and mechanism studies in humans remain limited.

References

• Talebi SM et al. (2024). Chemical composition and antimicrobial activity of the essential oils in different populations of Coriandrum sativum L. Food Science & Nutrition (PMC11167142)
• Coriander Cultivars Headspace Aroma and Essential Oils. PMC8891447 (2022)
• Coriandrum sativum L. essential oil: Chemistry and biological activity. Journal of Advanced Research (2015)
• Characterization of Coriander Seeds and Leaves: Volatile and Non-Volatile Extracts. International Journal of Food Properties (2011)
• Coriandrum sativum — Overview. ScienceDirect Topics
• Coriandrum sativum L.: A Review on Ethnopharmacology, Phytochemistry, and Cardiovascular Benefits. Molecules (2022). DOI: 10.3390/molecules27010209
• Coriandrum sativum L.: Ethnopharmacology, Phytochemistry, and Cardiovascular Benefits. PMC8747064 (2022)
• Effects of Dietary Supplementation with Coriander Seed Powder on Serum Lipid Profile, Glycemic Indices, and Oxidative Stress Biomarkers in Patients with T2DM: A Randomized, Double-Blind, Placebo-Controlled Trial. PMC12765609 (2025)
• The effects of coriander seed supplementation on serum glycemic indices, lipid profile and oxidative stress in T2DM: RCT. ResearchGate (2025)
• Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats. PubMed 21718774 (2011)
• The cholesterol-lowering property of coriander seeds: mechanism of action. PubMed 18831331 (2008)
• Antioxidant, antihyperglycemic, and antihyperlipidemic effects of Coriandrum sativum in alloxan-induced diabetic rats. PubMed 22671941 (2012)
• Potential of Coriandrum sativum in management of diabetes and hyperlipidemia: a comprehensive review. International Journal of Basic & Clinical Pharmacology (2025)
• Coriandrum sativum and Its Utility in Psychiatric Disorders. Molecules, PMC10385770 (2023)
• Anti-anxiety activity of Coriandrum sativum assessed using different experimental anxiety models. PMC3195130 (2011)
• Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review. PMC8554282 (2021)
• Inhalation of coriander volatile oil: anxiolytic–antidepressant-like behaviors in a beta-amyloid rat model of Alzheimer's. Physiology & Behavior (2014)
• Antioxidant, Antimicrobial and Antibiofilm Activity of Coriander Essential Oil for Application in Foods. PMC7142854 (2020)
• Coriandrum sativum L. essential oil as a promising source of bioactive compounds: GC/MS, antioxidant, antimicrobial activities. PMC11226197 (2024)
• Antibacterial and Antifungal Activities of Spices (including coriander). PMC5486105 (2017)
• Coriander essential oil and linalool — interactions with antibiotics against Gram-positive and Gram-negative bacteria. Letters in Applied Microbiology (2019)
• The effect of Jordanian essential oil from coriander seeds on antioxidant, anti-inflammatory, and immunostimulatory activities. PMC11302854 (2024)
• Antimicrobial Activity and Metabolomic Analysis of Linalool Against MRSA. PMC11812441 (2025)
• ClinicalTrials.gov NCT05999071: Coriandrum sativum Seeds — Memory, Anxiety, Depression, and Sleep Quality in University Students (RCT)
• EMA: Assessment Report on Pimpinella anisum — Cross-reactivity in Apiaceae including Coriander
• EMA Herbal Monograph: Carvi aetheroleum — Apiaceae Cross-Sensitivity including Coriander
• EFSA: Safety of Coriander Seed Oil as a Novel Food Ingredient (2013)
• EFSA: Safety and efficacy of coriander oil as a feed additive (2023)
• Coriander (Coriandrum sativum L.) and its bioactive constituents. Fitoterapia (2015)
• Klemow KM. Medical Attributes of Coriandrum sativum. Wilkes University (2012)
• Effect of Coriander Plants on Human Emotions, Brain Electrophysiology, and Salivary Secretion. PMC8698652 (2021)